Replies to post #20387 on Radient Pharmaceuticals Corporation fka RXPC

[runncoach]

So am I understanding you correctly that the "monitoring" was what already received rejection by the US patent office, and that the appeal was simply arguing the prior art that had already been included in the rejection?